Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • BGould
    Member
    • May 2010
    • 14

    #1

    Should one combine normalization methods in RNA-seq?

    Does anyone know if RPKM normalization and quantile normalization of RNA-seq read counts can or should be combined?

    For normalization of paired-end reads in RNA-seq, is it accurate to normalize the raw read counts using the quantile method, then following that calculate the RPKM value for each transcript using the quantile normalized values?

    It seems that RPKM normalization using the total millions of mapped reads is somewhat redundant with an initial quantile normalization of read counts. Are these two methods mutually exclusive or should they be combined? Any recommendations?

    thanks!
  • Macspider
    Member
    • Feb 2016
    • 36

    #2
    It's a bit late for this answer but maybe future users will benefit from that:
    When you use FPKM / RPKM as a measure unit you already have a normalized unit, which accounts for the gene length. However, when you have many samples sometimes you have different sequencing depths and thus different expression values that are the same thing but at two different depths. To account for that, using a global scaling or a full quantile normalization will help. In fact, when doing it you will end up with all the different "lanes" having the same statistical properties and thus remove the problem of the sequencing depth.

    So, in conclusion, use RPKM/FPKM and then do a full quantile on all the samples, it works and is a good practice.

    Comment

    • dpryan
      Devon Ryan
      • Jul 2011
      • 3478

      #3
      A better solution would be to never use RPKM/FPKM, since it tends to kill your statistical power, which is related to the raw counts and gets normalized away by the RPKM transformation.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      14 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      21 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-13-2026, 09:56 AM
      0 responses
      20 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-09-2026, 11:14 AM
      0 responses
      27 views
      0 reactions
      Last Post SEQadmin2  
      Working...